Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
The role of the glutamatergic system in posttraumatic stress disorder Nair J; Singh Ajit SCNS Spectr 2008[Jul]; 13 (7): 585-91Antiglutamatergic agents, such as lamotrigine, have been used successfully for the treatment of posttraumatic stress disorder (PTSD). They could be potentially acting through the stabilization of the corticotropin-releasing factor (CRF) systems. Glutamate mediates CRF release in various brain regions involved in the pathophysiology of PTSD, antiglutamatergic agents could stabilize the CRF system and, thereby, improve the symptom complex of PTSD (reexperiencing, hyperarousal, and avoidance). The role of glutamate and CRF in PTSD and other anxiety disorders are still being elucidated. However, it is clear that the glutamatergic systems play a role in the pathophysiology of PTSD.|Animals[MESH]|Calcium Channel Blockers/therapeutic use[MESH]|Corticotropin-Releasing Hormone/metabolism/*physiology[MESH]|Glutamic Acid/metabolism/*physiology[MESH]|Humans[MESH]|Hypothalamo-Hypophyseal System/metabolism/physiopathology[MESH]|Lamotrigine[MESH]|Pituitary-Adrenal System/metabolism/physiopathology[MESH]|Stress Disorders, Post-Traumatic/drug therapy/metabolism/*physiopathology[MESH]|Stress, Physiological/metabolism/physiopathology[MESH]|Triazines/therapeutic use[MESH] |
